loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Capsule Delayed Release Finished Formulations containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)? Find Methacrylic Acid Methyl Methacrylate Copolymer 1:1 based pharmaceutical excipients on PharmaCompass.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Methacrylic Acid Methyl Methacrylate Copolymer 1:1

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1DEXILANT

    02 3DIMETHYL FUMARATE

    03 1NEXIUM 24HR

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ACCORD HLTHCARE

    DIMETHYL FUMARATE

    arrow
    FNCE 2024
    Not Confirmed
    ACCORD HLTHCARE
    United Kingdom
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210499

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ASTRAZENECA LP

    ESOMEPRAZOLE MAGNESIUM

    arrow
    FNCE 2024
    Not Confirmed
    ASTRAZENECA LP
    United Kingdom
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ESOMEPRAZOLE MAGNESIUM

    Drug : NEXIUM 24HR

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 204655

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    CIPLA

    DIMETHYL FUMARATE

    arrow
    FNCE 2024
    Not Confirmed
    CIPLA
    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210305

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GLENMARK PHARMS LTD

    DIMETHYL FUMARATE

    arrow
    FNCE 2024
    Not Confirmed
    GLENMARK PHARMS LTD
    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210309

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    TAKEDA PHARMS USA

    DEXLANSOPRAZOLE

    arrow
    FNCE 2024
    Not Confirmed
    TAKEDA PHARMS USA
    Japan
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DEXLANSOPRAZOLE

    Drug : DEXILANT

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 22287

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF